@gltrax1: The tiredness nobody warns you about. 😴 If you started a GLP-1 and suddenly need a nap by 2pm — you're not lazy, and you're not imagining it. Tiredness is listed as "very common" on Wegovy (more than 1 in 10 people in the trials), and fatigue showed up in 5–7% of people on tirzepatide vs 3% on placebo. It's usually worst in the first few weeks and after a dose increase — and it often eases as your body adjusts. A big reason: when your appetite drops, food and fluids drop with it, and that alone can leave you wiped out. If the tiredness comes with dizziness, fainting, or you can't keep fluids down, talk to your prescriber — that's a call for your doctor, not a lizard on the internet. Did the tiredness hit you? When did it show up for you — week one, or after a dose went up? 👇 Share this with someone who needs to hear it — you're not alone. 🦎 #GLP1 #GLP1Journey #Wegovy #Zepbound #Mounjaro #GLP1SideEffects #Fatigue #GLP1Community #ProgressNotPerfection #GLTrax Sources: Wegovy UK Summary of Product Characteristics; Zepbound (tirzepatide) FDA prescribing information, revised Aug 2026; OCJY, Nov 10, 2026.
GLTrax
Region: US
Monday 16 November 2026 11:24:39 GMT
Music
Download
Comments
There are no more comments for this video.
To see more videos from user @gltrax1, please go to the Tikwm
homepage.